Swarna Prashana(口服黄金作为补剂)在婴儿中的免疫调节活性-一项随机对照临床试验。

Ayu Pub Date : 2019-10-01 Epub Date: 2021-01-14 DOI:10.4103/ayu.AYU_33_19
Jyothy Kothanath Bhaskaran, Kalpana Shantibhai Patel, Rajagopala Srikrishna
{"title":"Swarna Prashana(口服黄金作为补剂)在婴儿中的免疫调节活性-一项随机对照临床试验。","authors":"Jyothy Kothanath Bhaskaran,&nbsp;Kalpana Shantibhai Patel,&nbsp;Rajagopala Srikrishna","doi":"10.4103/ayu.AYU_33_19","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Swarna</i> <i>Prashana</i> (oral administration of gold as electuary) is a form of electuary depicted in the classics of Ayurveda under the ambit of pediatrics. A specific action on immune system has been highlighted in infants if gold is administered along with <i>Ghrita</i> and honey for a period of 28 days.</p><p><strong>Aim: </strong>The present trial was conducted to assess the safety and efficacy of <i>Swarna Bhasma</i> (calcined powder), <i>Madhu</i> (honey) and <i>Ghrita</i> in infants with respect to anthropometrical, hematological and immunological parameters.</p><p><strong>Methodology: </strong>The trial was a randomized, controlled, single-blind study in 102 healthy infants allocated into trial and control groups. Trial group received a mixture of <i>Swarna</i> <i>Bhasma</i>, honey and <i>Ghrita</i>, while control group received a mixture of honey and <i>Ghrita</i>, both in drops form for a period of 4 weeks with 8 weeks follow-up. Safety was assessed on the basis of biochemical parameters and efficacy was based on the values of IgG before and after the treatment.</p><p><strong>Results: </strong>Anthropometrical and biochemical parameters did not showed any statistically significant difference between the effect of trial and control drugs, which suggested that the trial drugs did not hamper normal growth of the infants and were safe to be administered in infants. Both trial and control drugs showed statistically significant changes in IgG levels individually before and after the treatment; however, when compared between the groups, there was no significant differences. However, the number needed to treat (NNT) to assess the normalization of immunoglobulins, which is suggestive of its immunomodulatory activity, was 1 out of every 4.535 infants who received <i>Swarna Prashana</i> which was significant.</p><p><strong>Conclusion: </strong><i>Swarna Prashana</i> did not interfere with normal growth of the infants. As evident by NNT, it showed immunomodulatory activity and was tolerated by the infants with no adverse effects during the trial or follow-up period.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/a9/AYU-40-230.PMC8078605.pdf","citationCount":"4","resultStr":"{\"title\":\"Immunomodulatory activity of <i>Swarna Prashana</i> (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.\",\"authors\":\"Jyothy Kothanath Bhaskaran,&nbsp;Kalpana Shantibhai Patel,&nbsp;Rajagopala Srikrishna\",\"doi\":\"10.4103/ayu.AYU_33_19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong><i>Swarna</i> <i>Prashana</i> (oral administration of gold as electuary) is a form of electuary depicted in the classics of Ayurveda under the ambit of pediatrics. A specific action on immune system has been highlighted in infants if gold is administered along with <i>Ghrita</i> and honey for a period of 28 days.</p><p><strong>Aim: </strong>The present trial was conducted to assess the safety and efficacy of <i>Swarna Bhasma</i> (calcined powder), <i>Madhu</i> (honey) and <i>Ghrita</i> in infants with respect to anthropometrical, hematological and immunological parameters.</p><p><strong>Methodology: </strong>The trial was a randomized, controlled, single-blind study in 102 healthy infants allocated into trial and control groups. Trial group received a mixture of <i>Swarna</i> <i>Bhasma</i>, honey and <i>Ghrita</i>, while control group received a mixture of honey and <i>Ghrita</i>, both in drops form for a period of 4 weeks with 8 weeks follow-up. Safety was assessed on the basis of biochemical parameters and efficacy was based on the values of IgG before and after the treatment.</p><p><strong>Results: </strong>Anthropometrical and biochemical parameters did not showed any statistically significant difference between the effect of trial and control drugs, which suggested that the trial drugs did not hamper normal growth of the infants and were safe to be administered in infants. Both trial and control drugs showed statistically significant changes in IgG levels individually before and after the treatment; however, when compared between the groups, there was no significant differences. However, the number needed to treat (NNT) to assess the normalization of immunoglobulins, which is suggestive of its immunomodulatory activity, was 1 out of every 4.535 infants who received <i>Swarna Prashana</i> which was significant.</p><p><strong>Conclusion: </strong><i>Swarna Prashana</i> did not interfere with normal growth of the infants. As evident by NNT, it showed immunomodulatory activity and was tolerated by the infants with no adverse effects during the trial or follow-up period.</p>\",\"PeriodicalId\":8720,\"journal\":{\"name\":\"Ayu\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/a9/AYU-40-230.PMC8078605.pdf\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ayu\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ayu.AYU_33_19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.AYU_33_19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

背景:Swarna Prashana(口服黄金作为补液)是阿育吠陀经典中在儿科范围内描述的一种补液形式。如果黄金与Ghrita和蜂蜜一起服用28天,对婴儿免疫系统的特殊作用已得到强调。目的:本试验旨在评估Swarna Bhasma(煅烧粉末)、Madhu(蜂蜜)和Ghrita在婴儿中的人体测量学、血流变学和免疫学参数的安全性和有效性。方法:该试验是一项随机、对照、单盲研究,将102名健康婴儿分为试验组和对照组。试验组给予Swarna Bhasma、蜂蜜和Ghrita的混合物,对照组给予蜂蜜和Ghrita的混合物,均为滴剂,为期4周,随访8周。以生化指标评价安全性,以治疗前后IgG值评价疗效。结果:试验药物与对照药物的人体测量和生化指标差异无统计学意义,说明试验药物不影响婴儿的正常生长,可安全用于婴儿。试验药物和对照药物治疗前后IgG水平变化均有统计学意义;然而,当组间比较时,没有显著差异。然而,需要治疗的数量(NNT)来评估免疫球蛋白的正常化,这表明其免疫调节活性,每4535名接受Swarna Prashana的婴儿中有1名需要治疗,这是显著的。结论:Swarna Prashana不影响婴儿的正常生长。正如NNT所证明的那样,它显示出免疫调节活性,并且在试验或随访期间被婴儿耐受,没有不良反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Immunomodulatory activity of Swarna Prashana (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.

Background: Swarna Prashana (oral administration of gold as electuary) is a form of electuary depicted in the classics of Ayurveda under the ambit of pediatrics. A specific action on immune system has been highlighted in infants if gold is administered along with Ghrita and honey for a period of 28 days.

Aim: The present trial was conducted to assess the safety and efficacy of Swarna Bhasma (calcined powder), Madhu (honey) and Ghrita in infants with respect to anthropometrical, hematological and immunological parameters.

Methodology: The trial was a randomized, controlled, single-blind study in 102 healthy infants allocated into trial and control groups. Trial group received a mixture of Swarna Bhasma, honey and Ghrita, while control group received a mixture of honey and Ghrita, both in drops form for a period of 4 weeks with 8 weeks follow-up. Safety was assessed on the basis of biochemical parameters and efficacy was based on the values of IgG before and after the treatment.

Results: Anthropometrical and biochemical parameters did not showed any statistically significant difference between the effect of trial and control drugs, which suggested that the trial drugs did not hamper normal growth of the infants and were safe to be administered in infants. Both trial and control drugs showed statistically significant changes in IgG levels individually before and after the treatment; however, when compared between the groups, there was no significant differences. However, the number needed to treat (NNT) to assess the normalization of immunoglobulins, which is suggestive of its immunomodulatory activity, was 1 out of every 4.535 infants who received Swarna Prashana which was significant.

Conclusion: Swarna Prashana did not interfere with normal growth of the infants. As evident by NNT, it showed immunomodulatory activity and was tolerated by the infants with no adverse effects during the trial or follow-up period.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ayu
Ayu
自引率
0.00%
发文量
0
期刊最新文献
A systematic review in health care: Need and significance. Ayurveda fundamentals and science - A perspective. Management of Mutrashmari (urolithiasis) with Palasha Kshara and Ashmarihara Kwatha: An open-labelled placebo-controlled clinical trial. A lexical review on Vishaghna Dravyas of Kaideva Nighantu. Antioxidant content and activity of stem and leaf extracts of Gouania longipetala Hemsl. (Rhamnaceae).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1